OPENLAB VERIFIED
Report identity and source-transcribed quantity. Compound purity and analytical events retain their separate source scopes.
EPISTANEMETHYL EPITIOSTANOL
- Batch
- OL2210
- Report
- 28862
- Laboratory
- Janoshik Analytical
- Analysed
- 16 April 2023
Powered by EvidenceOS, connecting this Olympus Labs UK product and batch to its laboratory results and source evidence.
Hover to inspect · enlarge for scroll, pan and zoom
Six checks for this batch.
- Product
- EPISTANE
- Batch
- OL2210
- Report
- 28862
- 01✓
- 02✓
- 03✓
- 04✓
- 05✓
Raw material to finished product
Follow the product from raw-material purity testing to the finished-product laboratory report. Each result describes a distinct stage.
- 01 · Raw-material sampleOwner-associated sample
Pre-production purity assay
- 02 · Raw-material lotIdentifier not supplied
Used in the production batch
- 03 · Production batchOL2210
Finished capsules
- 04 · Finished-product testJanoshik 28862
Concentration and identification
- Laboratory sample
- 1275-1
Production linkage and source coverage
The product owner confirms that the pre-production raw material was used in this production batch, whose finished capsules were sampled for concentration and identification testing. Laboratory observations retain their own sample and event identities.
Confirmed by Product owner, 2026-09-07. External identifiers remain unfilled where they were not supplied.
- External raw-material sample and lot identifiers are not supplied.
- Provider-original analytical PDF remains unavailable; the source image and PDF reproduction are admitted.
Analytical results
- Report
- 28862
- Batch
- OL2210
- Recorded
- 14 April 2023
- Signal
- PDA Ch1 220–260 nm
Sample 1275-1: 14.25 mg in the tested sample. The supplied image is a rendered chromatogram, not sampled waveform data.
OPENLAB / ANALYTICAL EVIDENCE
Concentration
Discrete quantity measurements from the selected analytical run.
View data table
| Peak | Retention time (min) | Quantity (mg) |
|---|---|---|
| 1 | 2.836 | 14.25 |
OPENLAB / ANALYTICAL EVIDENCE
Compound identity
The expected compound, observed identification and source conclusion stay together.
- Product
- EPISTANE
- Compound
- EPISTANE
- Alias
- METHYL EPITIOSTANOL
- Report
- 28862
OPENLAB / ANALYTICAL EVIDENCE
Measured quantity
The source result, with its original unit and sample basis.
- Compound
- EPISTANE
- Sample
- Reported sample; the laboratory gives mg without a per-capsule denominator.
OPENLAB / ANALYTICAL EVIDENCE
Reported purity
The source result, with its original unit and sample basis.
- Compound
- EPISTANE
- Sample
- Compound raw material
“>99.99%” means more than the stated amount. The source does not give an exact value above that limit.
Peak profile
- Analysis
- Compound reference
- Recorded
- 19 August 2022
- Signal
- DAD1 B, 220 nm
Earlier compound analysis · recorded separately from the 16 April 2023 batch report.
OPENLAB / ANALYTICAL EVIDENCE
Reported peak profile
Area and signal height describe different properties of each reported peak.
View data table
| Peak | Retention (min) | Area (%) | Height (mAU) | Width (min) |
|---|---|---|---|---|
| 1 | 26.11 | 100 | 157.11 | 0.27 |
OPENLAB / ANALYTICAL EVIDENCE
Epistane · LC/MS chromatogram · 2022-08-19
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
OPENLAB / ANALYTICAL EVIDENCE
Epistane · mass spectrum · 2022-08-19
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
OPENLAB / ANALYTICAL EVIDENCE
Epistane 28862 · analytical source image
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
Analytical methods
LC/MS
- Signal
- DAD1 B, 220 nm
- Recorded
- 19 August 2022
HPLC-DAD
- Signal
- PDA Ch1 220–260 nm
- Recorded
- 14 April 2023
- Testing ordered
- 31 March 2023
- Sample received
- 14 April 2023
- Analysed
- 16 April 2023
Janoshik Analytical
- Report
- 28862
- Batch
- OL2210
Explore the available findings and source evidence for EPISTANE.
EPISTANE
- Batch
- OL2210
- Report
- 28862